HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $421,690 | +11.0% | 3,645 | -1.4% | 0.04% | +17.6% |
| Q2 2023 | $380,031 | -8.2% | 3,695 | -2.6% | 0.03% | -10.5% |
| Q1 2023 | $414,186 | +41610.6% | 3,795 | -56.5% | 0.04% | -61.6% |
| Q4 2022 | $993 | -99.8% | 8,725 | -1.4% | 0.10% | +73.7% |
| Q3 2022 | $548,000 | -10.2% | 8,850 | +15.7% | 0.06% | -6.6% |
| Q2 2022 | $610,000 | -77.7% | 7,650 | -70.6% | 0.06% | -71.8% |
| Q1 2022 | $2,735,000 | -7.7% | 26,000 | -5.5% | 0.22% | -3.6% |
| Q4 2021 | $2,963,000 | -8.8% | 27,500 | -7.3% | 0.22% | -10.8% |
| Q3 2021 | $3,248,000 | -5.7% | 29,650 | -19.4% | 0.25% | -3.8% |
| Q2 2021 | $3,446,000 | +15.4% | 36,800 | +13.4% | 0.26% | +12.0% |
| Q1 2021 | $2,987,000 | +25.8% | 32,450 | 0.0% | 0.23% | +37.1% |
| Q4 2020 | $2,374,000 | -10.5% | 32,450 | -5.0% | 0.17% | -25.8% |
| Q3 2020 | $2,653,000 | +468.1% | 34,150 | +306.5% | 0.23% | +472.5% |
| Q2 2020 | $467,000 | – | 8,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |